Yates J, Whittington A, Mitchell P, Lechler R I, Lightstone L, Lombardi G
Department of Immunology, Hammersmith Hospital, Imperial College, London, UK.
Clin Exp Immunol. 2008 Jul;153(1):44-55. doi: 10.1111/j.1365-2249.2008.03665.x. Epub 2008 May 23.
CD4(+) CD25(+) regulatory T cells have been shown to be a vital component of the mechanisms that prevent autoreactivity in mice and also in humans. Previous studies have examined CD4(+) CD25(hi) regulatory T cell frequency and function in patients with systemic lupus erythematosus (SLE) with mixed results. We investigated frequency, phenotype and function in 21 patients with SLE and six with inactive disease. We found no reduction in frequency of the CD25(hi) subset, although active disease was associated with an increased proportion of CD4(+) CD25(+) T cells. When examining function, in the majority of individuals suppression was comparable with controls, although cells isolated from one patient with active disease failed to suppress proliferation. On testing the effect of CD25(hi) depletion on the responses of whole peripheral blood mononuclear cells to nucleosomes we found that, where a response was detectable from patients, depletion augmented interferon-gamma secretion, demonstrating intact suppression of responses implicated in the pathogenesis of SLE. Our results did not confirm an association of failure in CD4(+) CD25(hi) regulatory T cell function or a reduction in their frequency with active disease. Instead, perturbations in the CD4(+) CD25(hi) regulatory T cell population may play a role in disease in only a minority of the patients afflicted by the diverse syndromes of SLE.
CD4(+) CD25(+)调节性T细胞已被证明是防止小鼠和人类自身免疫反应机制的重要组成部分。先前的研究对系统性红斑狼疮(SLE)患者的CD4(+) CD25(hi)调节性T细胞频率和功能进行了检测,结果不一。我们调查了21例SLE患者和6例非活动性疾病患者的频率、表型和功能。我们发现CD25(hi)亚群的频率没有降低,尽管活动性疾病与CD4(+) CD25(+) T细胞比例增加有关。在检测功能时,大多数个体的抑制作用与对照组相当,尽管从一名活动性疾病患者分离的细胞未能抑制增殖。在测试CD25(hi)耗竭对全外周血单个核细胞对核小体反应的影响时,我们发现,在患者可检测到反应的情况下,耗竭会增加干扰素-γ分泌,表明对SLE发病机制中涉及的反应有完整的抑制作用。我们的结果并未证实CD4(+) CD25(hi)调节性T细胞功能缺陷或其频率降低与活动性疾病有关。相反,CD(+) CD25(hi)调节性T细胞群体的扰动可能仅在少数受SLE多种综合征折磨的患者的疾病中起作用。